Suppression of carcinogenesis in the intestines of Min mice by the soybean-derived Bowman-Birk inhibitor

Cancer Research

Volumn 56, Issue 4, 1996, Pages 679-682

  Kennedy, Ann R ^a,d   Beazer Barclay, Yasmin ^b   Kinzler, Kenneth W ^b   Newberne, Paul M ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOWMAN BIRK INHIBITOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CANCER INHIBITION; CANCER SUSCEPTIBILITY; COLON CARCINOGENESIS; CONTROLLED STUDY; FEMALE; INTESTINE CANCER; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ANIMALS; ANTICARCINOGENIC AGENTS; COLONIC NEOPLASMS; CROSSES, GENETIC; DIET; FEMALE; GROWTH; HUMANS; INTESTINAL NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; TRYPSIN INHIBITOR, BOWMAN-BIRK SOYBEAN;

EID: 0030059074     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Groden, J., Thliveris, A., Samowitz, W., Carlson, M., Gelbert, L , Albertsen, H , Joslyn, G., Stevens, J., Spirio, L., Robertson, M., Sargeant, L., Krapcho, K., Wolff, E , Burt, R., Hughes, J. P., Warrington, J., McPherson, J., Wasmuth, J., Le Paslier, D., Abderrahim, H , Cohen, D., Leppert, M. and White, R. Identification and characterization of the familial adenomatous polyposis coli gene. Cell, 66: 589-600, 1991.
2. Joslyn, G., Carlson, M., Thliveris, A., Albertsen, H , Gelbert, L , Samowitz, W., Groden, J., Stevens, J., Spino, L , Robertson, M , Sargeant, L , Krapcho, K., Wolff, E., Burt, R., Hughes, J. P , Warrington, J., McPherson, J., Wasmuth, J., Le Paslier, D., Abderrahim, H., Cohen, D., Leppert, M., and White, R. Identification of deletion mutations and three new genes at the familial polyposis locus. Cell, 66: 601-613, 1991.
3. Kinzler, K. W., Nilbert, M. C., Su, L-K., Vogelstein, B., Bryan, T. M., Levy, D B , Smith, K. J , Preisinger, A C., Hedge, P., McKechnie, D., Finniear, R., Markham, A , Groffen, J , Boguski, M. S., Altschul, S. F , Horii, A , Ando, H., Miyoshi, Y., Miki, Y , Nishisho, I., and Nakamura, Y. Identification of FAP locus genes from chromosome 5q21. Science (Washington DC), 253: 661-665, 1991.
4. Nishisho, I., Nakamura, Y , Miyoshi, Y., Miki, Y., Ando, H., Horii, A , Koyama, K., Utsunomiya, J., Baba, S., Hedge, P., Markham, A., Krush, A J , Petersen, G., Hamilton, S. R., Nilbert, M. C., Levy, D. B , Bryan, T. M , Preisinger, A. C., Smith, K. J., Su, L-K , Kinzler, K. W., and Vogelstein, B. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science (Washington DC), 253. 665-669, 1991.
5. Nagase, H , and Nakamura, Y Mutations of the APC (adenomatous polyposis coli) gene. Hum Mutat , 2 425-434, 1993.
6. Moser, A. R., Pitot, H. C., and Dove, W. F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science (Washington DC), 247: 322-324, 1990.
7. Su, L-K., Kinzler, K. W., Vogelstein, B., Preisinger, A. C , Moser, A R., Luongo, C., Gould, K A., and Dove, W. F. Intestinal neoplasia caused by a mutation in the murine homolog of the APC gene Science (Washington DC), 256: 668-670, 1992.
8. Moser, A. R., Dove, W. F , Roth, K. A., and Gordon, J I. The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system. J. Cell Biol., 116: 1517-1526, 1992.
9. Dietrich, W. F., Lander, E. S., Smith, J. S., Moser, A. R., Gould, K. A., Luongo, C., Borenstein, N., and Dove, W. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell, 75: 631-639, 1993.
10. Boone, C. W., Kelloff, G. J., and Malone, W E. Identification of candidate cancer chemopreventive agents and their evaluation in animals and human clinical trials: a review Cancer Res., 50. 2-9, 1990.
11. Kennedy, A. R , Szuhaj, B. F., Newberne, P. M., and Billings, P. C. Preparation and production of a cancer chemopreventive agent, Bowman-Birk inhibitor concentrate Nutr. Cancer. 19: 281-302, 1993.
12. Kennedy, A R. Overview: anticarcinogenic activity of protease inhibitors. In: W. Troll and A. R. Kennedy (eds), Protease Inhibitors as Cancer Chemopreventive Agents, pp 9-64. New York: Plenum Publishing Corp., 1993.
13. Kennedy, A R Prevention of carcinogenesis by protease inhibitors. Cancer Res., 54 (Suppl.): 1999s-2005s, 1994.
14. Kennedy, A R. Cancer prevention by protease inhibitors. Prev. Med., 22. 796-811, 1993.
15. Billings, P. C , St. Clair, W. H., Maki, P. A., and Kennedy, A. R. Distribution of the Bowman Birk protease inhibitor in mice following oral administration. Cancer Lett., 62: 191-197, 1992.
16. Billings, P C., Brandon, D. L , and Habres, J. M. Internalisation of the Bowman-Birk protease inhibitor by intestinal epithelial cells Eur. J. Cancer, 27: 903-908, 1991
17. Newberne, P M., and Rogers, A. E. Rat colon carcinomas associated with aflatoxin and marginal vitamin A. J. Natl Cancer Inst , 50: 439-448, 1973.
18. Yavelow, J , Collins, M., Birk, Y., Troll W., and Kennedy, A. R. Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress X-ray induced transformation in vitro. Proc. Natl. Acad. Sci USA, 82. 5395-5399, 1985
19. Billings, P. C., Carew, J. A., Keller-McGandy, C. E , Goldberg, A., and Kennedy, A. R. A senne protease activity in C3H/10T1/2 cells that is inhibited by anticarcinogenic protease inhibitors. Proc. Natl. Acad. Sci. USA, 84: 4801-4805, 1987.
20. Oreffo, V I. C., Billings, P. C., Kennedy, A. R , and Witschi, H. Acute effects of the Bowman-Birk protease inhibitor in mice. Toxicology, 69: 165-176, 1991.